325 related articles for article (PubMed ID: 26507224)
1. Antipsychotic prescribing for behavioral disorders in US youth: physician specialty, insurance coverage, and complex regimens.
Burcu M; Safer DJ; Zito JM
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):26-34. PubMed ID: 26507224
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
3. Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.
Aparasu RR; Bhatara V
Curr Med Res Opin; 2007 Jan; 23(1):49-56. PubMed ID: 17257465
[TBL] [Abstract][Full Text] [Related]
4. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
5. Trends in antipsychotic drug use by very young, privately insured children.
Olfson M; Crystal S; Huang C; Gerhard T
J Am Acad Child Adolesc Psychiatry; 2010 Jan; 49(1):13-23. PubMed ID: 20215922
[TBL] [Abstract][Full Text] [Related]
6. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
Olfson M; Blanco C; Liu L; Moreno C; Laje G
Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.
Burcu M; Zito JM; Ibe A; Safer DJ
J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):112-9. PubMed ID: 24690011
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
Sankaranarayanan J; Puumala SE
Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
[TBL] [Abstract][Full Text] [Related]
9. Trends in antipsychotic use for youth with attention-deficit/hyperactivity disorder and disruptive behavior disorders.
dosReis S; Saini J; Hong K; Reeves G; Spence OM
Pharmacoepidemiol Drug Saf; 2022 Jul; 31(7):810-814. PubMed ID: 35484637
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
11. Trends in prescribing of antipsychotic medications for US children.
Cooper WO; Arbogast PG; Ding H; Hickson GB; Fuchs DC; Ray WA
Ambul Pediatr; 2006; 6(2):79-83. PubMed ID: 16530143
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
13. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson TM; Xie J; Erder MH; Dammerman RS; Robertson B; Wu EQ
Am J Manag Care; 2014 Sep; 20(9):711-21. PubMed ID: 25365746
[TBL] [Abstract][Full Text] [Related]
14. Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.
Maust DT; Oslin DW; Marcus SC
J Am Geriatr Soc; 2014 Feb; 62(2):358-64. PubMed ID: 24417590
[TBL] [Abstract][Full Text] [Related]
15. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.
Bachmann CJ; Lempp T; Glaeske G; Hoffmann F
Dtsch Arztebl Int; 2014 Jan; 111(3):25-34. PubMed ID: 24606780
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
18. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
[TBL] [Abstract][Full Text] [Related]
19. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
20. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
